Advertisement

Advertisement

Most Viewed Videos
Christopher J. Recklitis, PhD, MPH, on Mental Health in Cancer Survivors
Gregory R. Pond, PhD, on Urothelial Cancer: Advance in Prognosis
Catherine C. Park, MD, on Novel Clinical Paradigms
Lisa A. Carey, MD, and Julie Gralow, MD: Top Breast Cancer Papers Presented at the 2016 ASCO Annual Meeting
Ursula A. Matulonis, MD, on Ovarian Cancer: Roundup of Studies on Olaparib, Cediranib, Mirvetuximab Soravtansine, Bevacizumab, and Pembrolizumab
Nathan Fowler, MD, and Sagar Lonial, MD, on Treating Follicular Lymphoma
Nicholas C. Turner, MD, PhD, Summarizes Results of the PALOMA3 Breast Cancer Study
Judith Paice, PhD, RN, on Neuropathic Pain
Nicholas J. van As, MD, on Prostate Cancer: Results From the PACE-B Trial Comparing Radiotherapy Techniques
Kenneth C. Anderson, MD, on Multiple Myeloma: Current Treatment Approaches and Future Directions
Bruce E. Johnson, MD, and Julie Vose, MD, MBA: A Conversation With ASCO’s 2017–2018 President
David I. Quinn, MBBS, PhD, on Urothelial Cancer: Results from KEYNOTE-045
Mark K. Ferguson, MD, on Mitigating Frailty and Sarcopenia to Improve Treatment Outcomes
Mark Talamonti, MD, on Pancreatic Cancer: Minimally Invasive Resection
Jonathan R. Strosberg, MD, on Neuroendocrine Tumors: Results of the NETTER-1 Trial
Julie Bryar Porter, MS, on Improving Care: One Center’s Experience
Jeff Dunn, AO, PhD, GAICD, on Community-Based Response to Cancer
Christian Carrie, MD, and Celestia S. Higano, MD, on Results of the GETUG-AFU 16 Trial on Prostate Cancer
Sumit K. Subudhi, MD, PhD, on Prostate Cancer: Results From the CheckMate 650 Trial on Nivolumab and Ipilimumab
Sumanta K. Pal, MD, and Toni K. Choueiri, MD, on Urothelial Carcinoma: Efficacy of an FGFR Inhibitor

Advertisement

Advertisement



Advertisement